Geneva, April 28 -- International Clinical Trials Registry received information related to the study (ChiCTR2600122587) titled 'Spatial multi-omics mechanism analysis and multimodal intelligent early warning of cachexia in pancreatic cancer' on April 15.
Study Type: Observational study
Study Design:
Sequential
Primary Sponsor: Peking Union Medical College Hospital
Condition:
Pancreatic cancer
Intervention:
Cachexia group:None
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-04-24
Target Sample Size: Cachexia group:300;Pre-cachexia group:200;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=312654
Published by HT Digital Content Services with pe...